首页 | 本学科首页   官方微博 | 高级检索  
检索        

湖北省结核分支杆菌耐药性监测研究
引用本文:李国明,吴兴荣,张缇,周丽平,李克国,刘勋,李爱国,戴宪法,袁方玉.湖北省结核分支杆菌耐药性监测研究[J].中华结核和呼吸杂志,2002,25(12):723-726.
作者姓名:李国明  吴兴荣  张缇  周丽平  李克国  刘勋  李爱国  戴宪法  袁方玉
作者单位:1. 430079,武汉,湖北省医学科学院结核病防治研究所
2. 湖北省卫生厅疾控处
3. 湖北省医学科学院
基金项目:WHO资助卫Ⅴ结核病控制项目
摘    要:目的 建立以世界卫生组织(WHO)和国际防痨和肺病联合会(IUATLD)指南为基础的结核病耐药监测系统,掌握湖北省初始和获得性耐药水平,评价现行结核病控制策略效果。方法 采用整群抽样方法,在全省随机抽取30个县(市,区)为监测点,各监测点连续选30个新发涂阳肺结核病例,期间的其他涂阳病例同时纳入,并对全部培养阳性菌株进行菌型鉴定及SM,INH,RFP,EMB4种抗结核药物的药敏试验(比例法)。结果 共入选1136例,其中培养阳性1097例,培养阳性率为96.6%,污染率为0.4%。总耐药率为23.3%,其中初始耐药率为17.5%,获得性耐药率为44.5%,初始耐多药率(含H+R)为2.1%。获得性耐多药率为21.8%。结论 初步建立了抗结核药物耐药性监测实验室方法和质量控制机制,首次获得可信的全省耐药水平资料。提示推行合理化疗和贯彻全程督导治疗原则对减少耐药的至关重要性和定期连续观测及深入研究的必要性。

关 键 词:湖北  肺结核  药物耐受性  监测  治疗
修稿时间:2002年3月14日

Surveillance of drug resistant tuberculosis in Hubei, China
LI Guoming ,WU Xingrong,ZHANG Ti,ZHOU Liping,LI Keguo,LIU Xun,LI Aiguo,DAI Xianfa,YUAN Fangyu ?Institute of Tuberculosis Control,Hubei Provincial Academy of Medical Sciences,Wuhan ,China.Surveillance of drug resistant tuberculosis in Hubei, China[J].Chinese Journal of Tuberculosis and Respiratory Diseases,2002,25(12):723-726.
Authors:LI Guoming  WU Xingrong  ZHANG Ti  ZHOU Liping  LI Keguo  LIU Xun  LI Aiguo  DAI Xianfa  YUAN Fangyu ?Institute of Tuberculosis Control  Hubei Provincial Academy of Medical Sciences  Wuhan  China
Institution:Institute of Tuberculosis Control, Hubei Provincial Academy of Medical Sciences, Wuhan 430079, China.
Abstract:Objectives To establish a surveillance system for antituberculous drug resistance according to WHO and IUATLD guidelines, to collect the data of initial and acquired drug resistance, and to evaluate the efficacy of ongoing tuberculosis control strategies Methods Thirty counties (or cities or districts) were randomly selected as surveillance points by cluster sampling Thirty new cases of smear positive pulmonary tuberculosis in each cluster were enrolled consecutively Bacterial typing and susceptibility tests (proportion method for SM,INH,RFP and EMB) were done in all culture positive samples Laboratory quality control was implemented by Korean Super country Reference Laboratory Data were analyzed by WHO SDRTB2 software Results 1 136 patients with pulmonary tuberculosis were enrolled in 30 clusters, among them 1 097 were culture positive Smear positive culture positive rate was 96 6% and the contamination rate was 0 4% The total drug resistance rate was 23 3%, the initial drug resistance being 17 5% and the acquired drug resistance being 44 5% The initial multi drug resistance rate (H+R) was 2 1% and the acquired multi drug resistance rate (H+R) was 21 8% Conclusions Laboratory methods for surveillance of drug resistant tuberculosis and quality control were established, and reliable data on the status of antituberculous drug resistance in Hubei province were collected The results showed that implementation of DOTS and regular surveillance were very important
Keywords:Tuberculosis  pulmonary  Drug resistance  Surveillance
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号